Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II
Phase 2
Recruiting
- Conditions
- Retinitis Pigmentosa
- Interventions
- Biological: 1.5 x 10^6 UC-MSC + CMBiological: 5 x 10^6 UC-MSC + CM
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 30
- Registration Number
- NCT05909488
- Locations
- 🇮🇩
RSUP Dr. Sardjito, Yogyakarta, DI Yogyakarta, Indonesia
Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa
- Conditions
- Retinitis Pigmentosa
- Interventions
- Biological: Umbilical Cord Mesenchymal Stem Cell (UC-MSC)Biological: Conditioned Medium (CM)
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 18
- Registration Number
- NCT05786287
- Locations
- 🇮🇩
Jakarta Eye Center Hospital, Jakarta, DKI Jakarta, Indonesia
🇮🇩Sardjito Hospital, Yogyakarta, Special Region, Indonesia
Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.
Phase 1
Recruiting
- Conditions
- Polycystic Ovary Syndrome
- Interventions
- Biological: UC-MSCsBiological: UC-MSCs and SecretomesBiological: ControlBiological: Secretomes
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2022-09-26
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 40
- Registration Number
- NCT05279768
- Locations
- 🇮🇩
PT Prodia StemCell Indonesia, Jakarta, Indonesia
Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer
Phase 1
Recruiting
- Conditions
- Nasopharyngeal Cancer
- Interventions
- Biological: Allo-Dendritic-Secretome Adjuvant TherapyBiological: Auto-Dendritic Adjuvant Therapy
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2022-09-26
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 15
- Registration Number
- NCT05261750
- Locations
- 🇮🇩
PT Prodia StemCell Indonesia, Jakarta, Indonesia
Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct
Phase 1
Recruiting
- Conditions
- Ischemic Stroke
- Interventions
- Biological: Conditioned MediumProcedure: Neurologic and Neutrophic DrugsBiological: Umbilical Cord Mesenchymal Stem Cells
- First Posted Date
- 2021-08-17
- Last Posted Date
- 2022-09-26
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 15
- Registration Number
- NCT05008588
- Locations
- 🇮🇩
Gatot Soebroto Hospital, Jakarta Pusat, DKI Jakarta, Indonesia
🇮🇩PT Prodia StemCell Indonesia, Jakarta, Indonesia
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B
Phase 1
- Conditions
- Liver Cirrhoses
- Interventions
- Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell
- First Posted Date
- 2020-04-22
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 12
- Registration Number
- NCT04357600
- Locations
- 🇮🇩
Cipto Mangunkusumo hospital, Jakarta, DKI Jakarta, Indonesia
Stem Cell in Acute Myocardial Infarction
Phase 1
Completed
- Conditions
- Acute Myocardial Infarction
- Interventions
- Biological: Mesenchymal Stem Cells
- First Posted Date
- 2020-04-09
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 4
- Registration Number
- NCT04340609
- Locations
- 🇮🇩
PT Prodia StemCell Indonesia, Jakarta, Indonesia
Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid
Phase 1
- Conditions
- Keloid
- Interventions
- Biological: Umbilical Cord-Mesenchymal Stem Cells and Conditioned MediumBiological: Triamcinolone AcetonideBiological: Conditioned Medium
- First Posted Date
- 2020-03-30
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 24
- Registration Number
- NCT04326959
Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa
Phase 1
Completed
- Conditions
- Retinitis Pigmentosa
- Interventions
- Biological: Conditioned Medium (CM)Biological: Umbilical Cord Mesenchymal Stem Cell (UC-MSC)
- First Posted Date
- 2020-03-19
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 18
- Registration Number
- NCT04315025
- Locations
- 🇮🇩
Sardjito Hospital, Yogyakarta, Special Region, Indonesia
🇮🇩Jakarta Eye Center Hospital, Jakarta, DKI Jakarta, Indonesia
Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis
Phase 1
Recruiting
- Conditions
- Osteoarthritis, Knee
- Interventions
- Biological: Arthroscopy with Mesenchymal Stem Cells + Secretome + SecretomeBiological: Arthroscopy with Secretome + Mesenchymal Stem Cells + SecretomeBiological: Non Arthroscopy with Mesenchymal Stem Cells + Secretome + SecretomeBiological: Non Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome
- First Posted Date
- 2020-03-19
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- PT. Prodia Stem Cell Indonesia
- Target Recruit Count
- 20
- Registration Number
- NCT04314661
- Locations
- 🇮🇩
Gatot Soebroto Hospital, Jakarta Pusat, DKI Jakarta, Indonesia
© Copyright 2025. All Rights Reserved by MedPath